HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Camurati-Engelmann disease: failure of response to bisphosphonates: report of two cases.

Abstract
Camurati-Engelmann disease is a rare bone disorder characterized by cortical thickening of the diaphysis of tubular bones, with sparing of the epiphysis. It has variable degrees of penetrance and expression, but may be very disabling for the affected individuals who manifest the painful symptoms. The authors report on two women with typical presentation of severe Camurati-Engelmann disease whose treatment with bisphosphonates failed to add any improvement beyond that elicited by corticosteroids alone.
AuthorsGlaucio R W Castro, Simone Appenzeller, João Francisco Marques-Neto, Manoel B Bértolo, Adil M Samara, Ibsen Coimbra
JournalClinical rheumatology (Clin Rheumatol) Vol. 24 Issue 4 Pg. 398-401 (Aug 2005) ISSN: 0770-3198 [Print] Germany
PMID15660289 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Diphosphonates
Topics
  • Adult
  • Bone Density (physiology)
  • Camurati-Engelmann Syndrome (diagnosis, drug therapy)
  • Densitometry
  • Diphosphonates (administration & dosage)
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Female
  • Follow-Up Studies
  • Humans
  • Rare Diseases
  • Severity of Illness Index
  • Treatment Failure

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: